Integrity Applications Signs Two Additional Distribution Agreements For Its Glucotrack® Model DF-F Glucose Monitoring Device

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ASHKELON, Israel--(BUSINESS WIRE)--Integrity Applications, Inc. (OTCQB: IGAP), developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, has entered, through its wholly-owned subsidiary, Integrity Applications Ltd., into distribution agreements for the GlucoTrack device in the Philippines and in Chile. According to the International Diabetes Federation, a total of about 3.3 million people with diabetes, or 6 percent of the adult population, live in the Philippines, and a total of about 1.3 million people with diabetes, or 10.4 percent of the adult population, live in Chile. This is its second distribution agreement in Asia and the second distribution agreement in South America.

Help employers find you! Check out all the jobs and post your resume.

Back to news